# Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers

> **NCT02257398** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 55 (actual)

## Conditions studied

- Infections, Respiratory Tract

## Interventions

- **DRUG:** GSK2140944
- **DRUG:** GSK2140944 placebo
- **DRUG:** Moxifloxacin
- **DRUG:** Moxifloxacin placebo

## Key facts

- **NCT ID:** NCT02257398
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-06
- **Primary completion:** 2015-03-02
- **Final completion:** 2015-03-02
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02257398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02257398, "Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02257398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*